Iman A Basheti1, Rajaa A Al-Qudah2, Nathir M Obeidat3, Nailya R Bulatova2. 1. Department of Clinical Pharmacy and Therapeutics, Applied Sciences University, Amman, Jordan. dr_iman@asu.edu.jo. 2. Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, Jordan. 3. Department of Internal Medicine, Respiratory and Sleep Medicine, Faculty of Medicine, The University of Jordan & Jordan University Hospital, Amman, Jordan.
Abstract
BACKGROUND: Medication Management Review (MMR) is a patient-focused, structured and collaborative health care service provided in the community setting to optimize patient understanding and quality use of medicines. OBJECTIVE: To conduct a randomized control trial of the MMR program in Jordan, by a pharmacist identifying treatment related problems (TRPs) through home visits, assessing type and frequency of TRPs, and eventual effect of resolving TRPs identified by the pharmacist and accepted by the physician on the health status of participating patients. SETTING:Outpatient clinic at the Jordan University Hospital, Amman, Jordan. METHOD:Consecutive patients from outpatient clinics who were eligible for the study were recruited and randomly distributed into two groups (control and intervention). All patients were visited at home by the pharmacist who delivered only forintervention group counseling regarding self-reported adherence, frequency of monitoring and education regarding pharmacological and non-pharmacological therapy. After identifying TRPs, the pharmacist sent a letter to the physician with certain recommendations for patients in the intervention group only. Physician ticked the approved recommendations and returned the report to the pharmacist, allowing the pharmacist to convey the approved changes to the patients. Patients were referred back to their physicians for confirmation of any changes in treatment. Both groups were reassessed after 2-3 months during their regular follow-up visits to their physicians. MAIN OUTCOME MEASURE: To assess the impact of home medication review on the number of TRPs and self-reported adherence in outpatients with chronic diseases via hospital-based clinics in Jordan. RESULTS: A total of 158 TRPs were identified in 112 patients; mean TRP number was 1.63 per patient. As a result of the pharmacist intervention, there was a significant decrease in number of TRPs in the intervention group, the change in the mean was (1.23 (±1.19), P < 0.001) versus the control group (0.29 (±1.24), P = 0.114). After 3 months, a reduction in non-adherence was observed in the intervention (-0.81 (±1.48), P < 0.001) in contrast to no change in self-reported adherence in the control (0.22 (± 1.12), P = 0.168) group. CONCLUSION: Overall, home-based medication review for patients with chronic conditions decreased the total number of TRPs and improved patient self-reported adherence.
RCT Entities:
BACKGROUND: Medication Management Review (MMR) is a patient-focused, structured and collaborative health care service provided in the community setting to optimize patient understanding and quality use of medicines. OBJECTIVE: To conduct a randomized control trial of the MMR program in Jordan, by a pharmacist identifying treatment related problems (TRPs) through home visits, assessing type and frequency of TRPs, and eventual effect of resolving TRPs identified by the pharmacist and accepted by the physician on the health status of participating patients. SETTING:Outpatient clinic at the Jordan University Hospital, Amman, Jordan. METHOD: Consecutive patients from outpatient clinics who were eligible for the study were recruited and randomly distributed into two groups (control and intervention). All patients were visited at home by the pharmacist who delivered only for intervention group counseling regarding self-reported adherence, frequency of monitoring and education regarding pharmacological and non-pharmacological therapy. After identifying TRPs, the pharmacist sent a letter to the physician with certain recommendations for patients in the intervention group only. Physician ticked the approved recommendations and returned the report to the pharmacist, allowing the pharmacist to convey the approved changes to the patients. Patients were referred back to their physicians for confirmation of any changes in treatment. Both groups were reassessed after 2-3 months during their regular follow-up visits to their physicians. MAIN OUTCOME MEASURE: To assess the impact of home medication review on the number of TRPs and self-reported adherence in outpatients with chronic diseases via hospital-based clinics in Jordan. RESULTS: A total of 158 TRPs were identified in 112 patients; mean TRP number was 1.63 per patient. As a result of the pharmacist intervention, there was a significant decrease in number of TRPs in the intervention group, the change in the mean was (1.23 (±1.19), P < 0.001) versus the control group (0.29 (±1.24), P = 0.114). After 3 months, a reduction in non-adherence was observed in the intervention (-0.81 (±1.48), P < 0.001) in contrast to no change in self-reported adherence in the control (0.22 (± 1.12), P = 0.168) group. CONCLUSION: Overall, home-based medication review for patients with chronic conditions decreased the total number of TRPs and improved patient self-reported adherence.
Authors: Andrew C Stafford; Peter C Tenni; Gregory M Peterson; Shane L Jackson; Anne Hejlesen; Christine Villesen; Mette Rasmussen Journal: Pharm World Sci Date: 2009-02-26
Authors: Melissa Somma McGivney; Susan M Meyer; Wendy Duncan-Hewitt; Deanne L Hall; Jean-Venable R Goode; Randall B Smith Journal: J Am Pharm Assoc (2003) Date: 2007 Sep-Oct
Authors: Johan Granados; Pedro Amariles; Juan Pablo Botero-Aguirre; Natalia Andrea Ortiz-Cano; Andrés-Felipe Valencia-Quintero; Andrea Salazar-Ospina Journal: Int J Clin Pharm Date: 2022-01-03
Authors: Tareq L Mukattash; Anan S Jarab; Ibrahim Mukattash; Mohammad B Nusair; Rana Abu Farha; May Bisharat; Iman A Basheti Journal: Pharm Pract (Granada) Date: 2020-07-31